Private equity continuation funds are a strategic liquidity tool that allows a general partner (GP) to transfer high-performing portfolio assets from an existing fund into a newly created vehicle. This process, known as a GP-led secondary transaction, enables the GP to extend the hold period for high-conviction assets that may need additional time or growth capital to reach their full potential.
Here is how the process works:
- Asset Selection: A GP identifies one or more assets—often through a single-asset continuation vehicle for a specific high-performing company—and moves them from a legacy fund to the new vehicle.
- Liquidity Options: Existing limited partners (LPs) are typically offered a clear choice: they can sell their interest for cash at a price determined by a third-party valuation or secondary market process, or they can roll their stake into the new fund to maintain exposure to future upside.
- New Capital Injection: The new vehicle is usually capitalized by a combination of rolling LPs and fresh capital from new institutional investors.
As a Boutique M&A and Capital Advisory Firm, we utilize a Full-Cycle M&A framework to evaluate these complex structures. These vehicles are particularly effective when traditional exit paths, such as an IPO or trade sale, are delayed, as they provide a strategic alternative to a forced sale while maintaining alignment between the GP and the asset’s long-term growth.
Disclaimer: This website is for informational purposes only and is not an offer, solicitation, recommendation, or commitment to buy or sell any security or financial product. Securities are offered through Finalis Securities LLC; Zaidwood Capital is not a registered broker-dealer and is unaffiliated with Finalis. Investments involve risk and are not guaranteed to appreciate; investors may lose all or part of their investment.
Related FAQs
-
What does M&a Due Diligence Typically Involve?
Read More »: What does M&a Due Diligence Typically Involve?As a Boutique M&A and Capital Advisory Firm, we approach M&A due diligence as a rigorous, three-phase process designed to mitigate risk and uncover hidden value. Our Full-Cycle M&A advisory ensures that every transaction is supported by data-driven confidence. Typically,…
-
How do Regulatory Changes Affect Healthcare M&a Deals?
Read More »: How do Regulatory Changes Affect Healthcare M&a Deals?Regulatory changes act as a fundamental driver in the healthcare sector, directly shaping deal timelines, valuation methodologies, and the overall feasibility of transactions. As a Boutique M&A and Capital Advisory Firm, we observe that these shifts require rigorous financial analysis…
-
What are the Key Trends in Healthcare Mergers and Acquisitions over the past Three Months?
Read More »: What are the Key Trends in Healthcare Mergers and Acquisitions over the past Three Months?The healthcare mergers and acquisitions landscape is currently defined by a fundamental transformation driven by private equity involvement, technological convergence, and shifting regulatory frameworks. In our role as a Boutique M&A and Capital Advisory Firm, we observe several key trends…
-
How Much does a Tech M&a Deal Typically Cost for Advisory Services?
Read More »: How Much does a Tech M&a Deal Typically Cost for Advisory Services?Advisory fees for technology mergers and acquisitions generally follow two primary models. The specific cost depends on the transaction value and the level of service required. The standard structures include: While specific percentages or dollar amounts vary based on the…
-
What are the Key Steps Involved in Tech Mergers and Acquisitions?
Read More »: What are the Key Steps Involved in Tech Mergers and Acquisitions?Navigating technology mergers and acquisitions requires a structured framework designed to manage complexity and maximize value. The process involves several critical milestones: Related FAQs